Literature DB >> 20357336

Complications associated with distraction osteogenesis for infected nonunion of the femoral shaft in the presence of a bone defect: a retrospective series.

A L L Blum1, J C BongioVanni, S J Morgan, M A Flierl, F Baldy dos Reis.   

Abstract

We undertook a retrospective study of 50 consecutive patients (41 male, 9 female) with an infected nonunion and bone defect of the femoral shaft who had been treated by radical debridement and distraction osteogenesis. Their mean age was 29.9 years (9 to 58) and they had a mean of 3.8 (2 to 19) previous operations. They were followed for a mean of 5.9 years (2.0 to 19.0). The mean duration of the distraction osteogenesis was 24.5 months (2 to 39). Pin-track infection was observed in all patients. The range of knee movement was reduced and there was a mean residual leg-length discrepancy of 1.9 cm (0 to 8) after treatment. One patient required hip disarticulation to manage intractable sepsis. In all, 13 patients had persistent pain. Bony union was achieved in 49 patients at a mean of 20.7 months (12 to 35). Although distraction osteogenesis is commonly used for the treatment of infected femoral nonunion with bone defects, it is associated with a high rate of complications.

Entities:  

Mesh:

Year:  2010        PMID: 20357336     DOI: 10.1302/0301-620X.92B4.23475

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  21 in total

1.  Local transplantation of bone marrow concentrated granulocytes precursors can cure without antibiotics infected nonunion of polytraumatic patients in absence of bone defect.

Authors:  Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Nathalie Chevallier; Helene Rouard; Charles Henri Flouzat-Lachaniette
Journal:  Int Orthop       Date:  2016-03-01       Impact factor: 3.075

Review 2.  Treatment of critical-sized bone defects: clinical and tissue engineering perspectives.

Authors:  Erika Roddy; Malcolm R DeBaun; Adam Daoud-Gray; Yunzhi P Yang; Michael J Gardner
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-10-28

3.  Treatment of atrophic femoral non-unions according to the diamond concept: Results of one- and two-step surgical procedure.

Authors:  Arash Moghaddam; Benjamin Thaler; Thomas Bruckner; Michael Tanner; Gerhard Schmidmaier
Journal:  J Orthop       Date:  2016-11-02

4.  A web-based survey to identify current practice in skeletal pin site management.

Authors:  Jennie A Walker; Brigitte E Scammell; Roger Bayston
Journal:  Int Wound J       Date:  2017-12-17       Impact factor: 3.315

Review 5.  [Complication management for failed bone fracture healing: pseudarthrosis].

Authors:  S Grechenig; C Pfeifer; W Krutsch; F Hilber; M Nerlich; A Berner
Journal:  Chirurg       Date:  2015-10       Impact factor: 0.955

Review 6.  Vascularization in bone tissue engineering constructs.

Authors:  Ángel E Mercado-Pagán; Alexander M Stahl; Yaser Shanjani; Yunzhi Yang
Journal:  Ann Biomed Eng       Date:  2015-01-24       Impact factor: 3.934

7.  Antibiotic cement-coated locking plate as a temporary internal fixator for femoral osteomyelitis defects.

Authors:  Xin Yu; Hongri Wu; Jianhua Li; Zhao Xie
Journal:  Int Orthop       Date:  2016-08-13       Impact factor: 3.075

8.  Ilizarov distraction osteogenesis over the preexisting nail for treatment of nonunited femurs with significant shortening.

Authors:  Wael Azzam; Mohamed El-Sayed
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-01-25

9.  The use of twin-ring Ilizarov external fixator constructs: application and biomechanical proof-of principle with possible clinical indications.

Authors:  Theodoros B Grivas; Evangelos A Magnissalis
Journal:  J Orthop Surg Res       Date:  2011-08-11       Impact factor: 2.359

10.  Infected nonunion of tibia and femur treated by bone transport.

Authors:  Peng Yin; Lihai Zhang; Tongtong Li; Licheng Zhang; Guoqi Wang; Jiantao Li; Jianheng Liu; Jianfeng Zhou; Qun Zhang; Peifu Tang
Journal:  J Orthop Surg Res       Date:  2015-04-10       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.